What is the CanAssist Breast test?

CanAssist Breast is a prognostic test that helps predict the risk of breast cancer recurrence and supports oncologists in personalizing treatment plans.

Who can benefit from the CanAssist Breast test?

It is suitable for patients diagnosed with early-stage, hormone receptor-positive breast cancer to determine their recurrence risk.

How accurate is the CanAssist Breast test?

CanAssist Breast has been validated on South Asian and Caucasian populations, demonstrating high accuracy in predicting recurrence risk.

Clinical Research Validating Breast Cancer Recurrence Risk Tests

BreastPath Connect 2025

Events and Conferences

May, 2025

Advancing Insights in Breast Pathology

View

19th St. Gallen International Breast Cancer Conference

Events and Conferences

March, 2025

Dr. D. G. Vijay Presents on CAB and Proteomics-Based Risk Stratification in HR+/HER2-Negative Breast Cancer

View

Celebrating Women Leaders in STEM

Events and Conferences

March, 2025

Dr. Manjiri Bakre Joins Healthcare & Science Tech Entrepreneurship Roundtable at Apollo Proton Cancer Centre’s ‘Celebrating Women Leaders in STEM

View

Asia Pacific Breast Cancer Summit

Events and Conferences

January, 2025

CanAssist Breast: Does it solve the unmet need for “Prognostication” in Asian ER+/HER2- early breast cancer patients?

View

Cureus Part of Spinger Nature

Scientific Publication by Renowned Oncologists Worldwide

January, 2025

Kumar, Rajeev et al: Comparison of Recurrence Risk Prediction by the CanAssist Breast Test and the PREDICT Online Tool in Early Breast Cancer Patients

View

Technology & Innovation in Healthcare Summit by Happiest Health

Events and Conferences

January, 2025

Technology & Innovation in Healthcare Summit by Happiest Health

View

Women in Tech at Global Entrepreneurship Conference

Events and Conferences

January, 2025

Internation Conference on Entrepreneurship and Entrepreneurial Ecosystem In the global economy

View

Scientific Publications